Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Carcinoma, Renal Cell × testosterone undecanoate × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Prostatic Neoplasms 1 Hypogonadism 1 Fatigue Syndrome, Chronic 1 Eunuchism 1 Carcinoma, Renal Cell 1

Interventions

Sunitinib 52 Nivolumab 45 Sorafenib 35 Bevacizumab 31 Axitinib 31 pembrolizumab 29 cabozantinib 28 Everolimus 25 pazopanib 23 aldesleukin 23 Ipilimumab 21 Interleukin-2 17 Magnetic Resonance Spectroscopy 15 Interferon-alpha 15 Gemcitabine 15 lenvatinib 13 Specimen Handling 13 Radiosurgery 12 Interferon alpha-2 12 Cyclophosphamide 12 fludarabine phosphate 11 Erlotinib Hydrochloride 8 temsirolimus 7 atezolizumab 7 Introns 7 Capecitabine 7 durvalumab 6 avelumab 6 Radiotherapy 6 Peripheral Blood Stem Cell Transplantation 6

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03379012 2019-10-22

FARETES

Kidney Cancer Research Bureau

Phase 2 Completed

Carcinoma, Renal Cell

Data powered by HemOnc (CC BY 4.0) Colophon ⚡